Characteristics of participants with and without new or progressive SCI, single variable
| Variable . | No new SCI (n = 20) . | New SCI (n = 8) . | P value . |
|---|---|---|---|
| Age, median (IQR), y | 45 (30-54.5) | 49 (48-51) | .165 |
| Female sex | 75% | 75% | 1.000 |
| Black race | 75% | 87.5% | .202 |
| Time from iTTP diagnosis, median (IQR), mo | 68 (6.5-109) | 14 (2-168) | .438 |
| Hypertension | 30% | 62.5% | .112 |
| Diabetes mellitus | 15% | 37.5% | .190 |
| Stroke during iTTP | 20% | 50% | .112 |
| ARWMC score at V1, median (IQR) | 1 (0-6) | 7 (4.25-9) | .011∗ |
| Average ADAMTS13 activity between V1 and V2, median (IQR) | 72 (50.5-94.0) | 95.5 (70.7-100.0) | .116 |
| Variable . | No new SCI (n = 20) . | New SCI (n = 8) . | P value . |
|---|---|---|---|
| Age, median (IQR), y | 45 (30-54.5) | 49 (48-51) | .165 |
| Female sex | 75% | 75% | 1.000 |
| Black race | 75% | 87.5% | .202 |
| Time from iTTP diagnosis, median (IQR), mo | 68 (6.5-109) | 14 (2-168) | .438 |
| Hypertension | 30% | 62.5% | .112 |
| Diabetes mellitus | 15% | 37.5% | .190 |
| Stroke during iTTP | 20% | 50% | .112 |
| ARWMC score at V1, median (IQR) | 1 (0-6) | 7 (4.25-9) | .011∗ |
| Average ADAMTS13 activity between V1 and V2, median (IQR) | 72 (50.5-94.0) | 95.5 (70.7-100.0) | .116 |
V1, visit 1; V2, visit 2.
∗indicates differences that are significant with P < 0.05